OMNISCOPE
Omniscope enables sequencing up to 1 million cells per sample at cellular resolution. These high definition repertoire profiles are deployed through our web based Omniscope Immune Portal (OS-IP), providing data and tools to enable discovery. For more information: https://www.omniscope.ai/immune-portal
OMNISCOPE
Industry:
Big Data Biotechnology Health Care
Founded:
2021-02-25
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.omniscope.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Euro IPv6 Cloudflare JS CDN JS
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
European Commission
European Commission investment in Grant - Omniscope
Friends & Family
Friends & Family investment in Pre Seed Round - Omniscope
Malta Enterprise
Malta Enterprise investment in Grant - Omniscope
Newest Events participated
Participated in Biotech Showcase: Investor and Partnering Conference in San Francisco
on 2022-01-12 as speaker
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-14 | Omniscope appoints Dr. Luciano Martelotto as Chief Technology Officer |
Official Site Inspections
http://www.omniscope.ai Semrush global rank: 9.45 M Semrush visits lastest month: 156
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
